HC-067047 is a selective antagonist of the TRPV4 ion channel, making it a valuable tool in scientific research focused on understanding the role of TRPV4 in physiological and pathological processes. It is widely used in studies related to pain perception, particularly in models of inflammatory and neuropathic pain, where TRPV4 activation contributes to hypersensitivity. Researchers apply HC-067047 to investigate its effects in reducing pain behaviors in animal models, helping to validate TRPV4 as a potential therapeutic target. It is also utilized in studies of bladder dysfunction, as TRPV4 plays a role in urinary bladder reflexes and overactivity. By blocking TRPV4 with HC-067047, scientists have observed reduced bladder hyperactivity in experimental models, suggesting its relevance in developing treatments for conditions like overactive bladder. Additionally, HC-067047 has been employed in research on lung injury and edema, where TRPV4 activation can exacerbate vascular permeability and inflammation. Inhibiting TRPV4 with this compound has shown protective effects in preclinical models of acute lung injury. Due to its selectivity and potency, HC-067047 is primarily used as a pharmacological probe in vitro and in vivo, supporting the development of new drugs targeting TRPV4-related diseases.